Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
Sonoyama, Takuhiro, Iwata, Satoshi, Shinkai, Masaharu, Iwata-Yoshikawa, Naoko, Shiwa-Sudo, Nozomi, Hemmi, Takuya, Ainai, Akira, Nagata, Noriyo, Matsunaga, Nobuaki, Tada, Yukio, Homma, Tomoyuki, Omoto, Shinya, Yokokawa Shibata, Risa, Igarashi, Kenji, Suzuki, Tadaki, Hasegawa, Hideki, Ariyasu, Mari
Published in Vaccine (10.03.2023)
Published in Vaccine (10.03.2023)
Get full text
Journal Article
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study
Shinkai, Masaharu, Sonoyama, Takuhiro, Kamitani, Akari, Shibata, Risa Yokokawa, Seki, Naomi M., Omoto, Shinya, Shinoda, Masahiro, Sato, Takashi, Ishii, Naoki, Igarashi, Kenji, Ariyasu, Mari
Published in Vaccine (30.07.2022)
Published in Vaccine (30.07.2022)
Get full text
Journal Article